Why well-insured patients should demand value-based insurance benefits

被引：12

作者：

Denny, Colleen C. ^{[1
]}

Emanuel, Ezekiel J. ^{[1
]}

Pearson, Steven D. ^{[1
]}

机构：

[1] NIH, Dept Bioeth, NIH Clin Ctr, Bethesda, MD 20892 USA

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2007年 / 297卷 / 22期

关键词：

D O I：

10.1001/jama.297.22.2515

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2515 / 2518

页数：4

共 23 条

[1]

AARON H, 2006, LOS ANGELES TIM 0130

[2] Employer-sponsored insurance - Riding the health care tiger [J].

Blumenthal, D .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (02) :195-202

[3] High and rising health care costs. Part 2: Technologic innovation [J].

Bodenheimer, T .

ANNALS OF INTERNAL MEDICINE, 2005, 142 (11) :932-937

[4] Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer [J].

Cunningham, D ;

Humblet, Y ;

Siena, S ;

Khayat, D ;

Bleiberg, H ;

Santoro, A ;

Bets, D ;

Mueser, M ;

Harstrick, A ;

Verslype, C ;

Chau, I ;

Van Cutsem, E .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (04) :337-345

[5]

DeNavas-Walt C., 2006, INCOME POVERTY HLTH

[6]

Deyo R. A., 2004, SPINE J, V4, p138S

[7]

Fendrick AM, 2001, AM J MANAG CARE, V7, P861

[8]

Fendrick AM, 2006, AM J MANAG CARE, V12, P18

[9] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[10]

*KAIS FAM FDN HLTH, 2005, EMPL HLTH BEN 2005 A

← 1 2 3 →